Ironwood Pharmaceuticals appointed Chief Commercial Officer Tammi Gaskins to succeed retiring CEO Tom McCourt as of January 1, 2027. The appointment signals a strategic leadership transition aimed at continuing the company's growth momentum in GI and rare disease therapies.